CASOLARI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 4297
EU - Europa 1070
AS - Asia 631
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 2
Totale 6013
Nazione #
US - Stati Uniti d'America 4296
CN - Cina 425
UA - Ucraina 317
IT - Italia 264
TR - Turchia 186
DE - Germania 156
GB - Regno Unito 109
SE - Svezia 88
FI - Finlandia 73
FR - Francia 25
PL - Polonia 16
BE - Belgio 11
VN - Vietnam 9
AU - Australia 7
IN - India 4
JP - Giappone 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
ES - Italia 2
EU - Europa 2
NZ - Nuova Zelanda 2
CA - Canada 1
CH - Svizzera 1
EG - Egitto 1
HK - Hong Kong 1
IE - Irlanda 1
IR - Iran 1
MA - Marocco 1
MK - Macedonia 1
NL - Olanda 1
NO - Norvegia 1
RO - Romania 1
RU - Federazione Russa 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 6013
Città #
Fairfield 641
Woodbridge 556
Houston 385
Jacksonville 378
Ann Arbor 281
Chandler 279
Ashburn 258
Seattle 225
Wilmington 218
Cambridge 205
Washington 197
Izmir 138
Nanjing 121
Princeton 86
Beijing 85
Ferrara 67
Boardman 55
Milan 47
San Diego 43
Dearborn 35
Addison 31
Nanchang 29
Shenyang 27
Hebei 26
Jiaxing 20
Changsha 17
Mountain View 16
Warsaw 16
Kunming 15
Tianjin 14
Bremen 13
Redwood City 12
Auburn Hills 11
Brussels 11
Jinan 11
Chicago 10
Guangzhou 10
Dong Ket 9
Falls Church 9
Norwalk 9
Orange 8
Taizhou 8
Los Angeles 7
Ningbo 7
Lanzhou 6
Zhengzhou 6
Augusta 5
Bologna 5
Catania 5
Hefei 5
Helsinki 5
Napoli 5
Philadelphia 5
Shanghai 5
Verona 5
Lecco 4
London 4
Redmond 4
San Mateo 4
Changchun 3
Des Moines 3
Littleton 3
Oristano 3
Padova 3
Rome 3
Aversa 2
Bolzano 2
Castelnuovo Rangone 2
Chongqing 2
Desio 2
Florence 2
Gossolengo 2
Indiana 2
Istanbul 2
Leawood 2
Messina 2
Monmouth Junction 2
Montalcino 2
Mori 2
Munich 2
New York 2
Paris 2
San Martino Valle Caudina 2
Torino 2
Vienna 2
Walnut 2
Yellow Springs 2
Alessandria 1
Ardabil 1
Asiago 1
Basel 1
Brisbane 1
Cachan 1
Casalnuovo Di Napoli 1
Chennai 1
Cinisello Balsamo 1
Dublin 1
Fuzhou 1
Gandhi Nagar 1
Greven 1
Totale 4794
Nome #
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 254
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 142
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 136
null 121
null 118
null 114
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 113
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 112
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 111
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. 107
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 104
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 103
null 102
Unbalanced oxidant-induced DNA damage and repair in COPD: A link towards lung cancer 101
Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot study. 101
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. 100
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 100
Recent thymic emigrants do not account for the increased number of T-cells seen in the lungs of stable chronic obstructive pulmonary disease 99
Mechanisms involved in lung cancer development in COPD 98
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 98
Reducing Agents Decrease the Oxidative Burst and Improve Clinical Outcomes in COPD Patients: A Randomised Controlled Trial on the Effects of Sulphurous Thermal Water Inhalation. 96
Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease 95
null 92
null 91
null 91
null 90
MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients 90
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 89
null 88
null 88
New drugs targeting Th2 lymphocytes in asthma 87
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 87
Targeting Th2 cells in asthmatic airways 86
Increased deposition of activated complement in peripheral lung vessels of smokers 86
Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus 83
null 81
null 81
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 80
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 79
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 74
Cellule staminali e patologia polmonare dell’adulto 71
Pathophysiology of viral-induced exacerbations of COPD 71
COPD immunopathology 67
Morte per asma. Parte I: fenotipi clinici, epidemiologia e fattori di rischio. 66
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 66
null 66
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 64
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis 64
Activation of NF-kappaB transcription factor in asthma death 63
COPD pathology in the small airways 62
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 62
Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease 59
TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD 58
Expression of transforming growth factors beta (1, 2, 3) and connective tissue growth factor in the peripheral lung from GOLD stage 1-2 COPD patients and smokers with normal lung function 58
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients 56
Th17-related cytokine expression is increased in the bronchial mucosa of stable COPD patients 56
Xanthine-Oxidase System Activation Is Required in Rhinovirus Induced Oxidant Production in Respiratory Epithelial Cells 56
Expression of Heat Shock Proteins 70 and 90 in COPD Peripheral Lung 55
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema 53
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 52
Expression of the phosphorylated myristoylated alanine-rich C kinase substrate (MARCKS) in COPD bronchial glands 51
null 51
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 50
Xanthine oxidase inhibitors reduce rhinovirus induced IL-8 and gro- production in bronchial epithelial cells. 49
Heat shock proteins 70 and 90 expression in peripheral lung of COPD patients 48
Mucin expression in the bronchiolar epithelium of patients with chronic obstructive pulmonary disease. 48
Inhibition of PI-3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice 47
Ruolo dei marcatori non invasivi di stress ossidativo nelle broncopneumopatie croniche ostruttive 47
Trattamento personalizzato dei pazienti con BPCO in fase stabile 42
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. 40
Ruolo dei fattori di crescita dell’endotelio vascolare e dei loro recettori nella patogenesi delle malattie polmonari dell’adulto: patologia. 39
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. Basi fisiologiche. I parte. 38
FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease 37
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive.Basi fisiologiche. II parte. 34
Ruolo delle infezioni virali nelle riacutizzazioni asmatiche. 34
Ruolo dei fattori di crescita dell’endotelio vascolare e dei loro recettori nella patogenesi delle malattie polmonari dell’adulto: fisiologia. 34
Glucocorticoids impair type I IFN signalling and enhance rhinovirus replication 23
Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6 22
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 18
Chemokines and chemokine receptors blockers as new drugs for the treatment of chronic obstructive pulmonary disease 17
Expression of adenosine receptors in the peripheral lung from COPD patients. 16
Definition and aetiology of infective exacerbations of COPD 15
Oxidative/nitrosative stress selectively altered A2B adenosine receptors in chronic obstructive pulmonary disease. 12
Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD 10
Nasal inflammation and its response to local glucocorticoid regular treatment in patients with persistent non-allergic rhinitis: a pilot study 8
Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. 7
Oxidative Stress-induced Antibodies to Carbonyl-modified Protein Correlate with Severity of Chronic Obstructive Pulmonary Disease 5
Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κb and c-Jun N-terminal kinase activation 5
Role of transcription factors in the pathogenesis of asthma and COPD 5
Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension. 4
Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension. 3
Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations 3
Totale 6155
Categoria #
all - tutte 11821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 536
Totale 12357


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018138 0000 00 00 6357810
2018/2019969 221123 99 1109 81162191360
2019/20201500 2404448215 99183 152169 1301425127
2020/20211073 727358140 39120 50120 23135132111
2021/2022730 26717054 2436 2649 225885209
2022/2023644 91212592 120107 3563 90000
Totale 6155